Our Company
Culture & Values
Leadership
Global Locations
Corporate Compliance
Subsidiaries & Joint Ventures
Diversity & Inclusion
20th Anniversary
Medicinal Chemistry
Compound Screening
DMPK
Safety & Toxicology
Bioanalytical
CMC
Medical Writing
Clinical Monitoring
Regulatory Affairs
Data Management and Statistical Analysis
Clinical Development Strategy
Decentralized Clinical Trials (DCTs)
Site Management (SMO)
Medical Device / IVD
Multi-region Clinical Trial (MRCT)
Vaccine Clinical Trial
Therapeutic Expertise
Radiopharmaceutical
Full Life-Cycle Support and Services for Radiopharmaceutical Development.
Radiopharmaceutical Clinical Development
With the development of precision medicine, the radiopharmaceuticals (nuclear medicine) sector is quietly heating up, especially under the guidance of clinical value. The research and development of radiopharmaceuticals is gradually moving from laboratories to clinical applications. Currently, the global market share of radiopharmaceuticals is less than 1%, but they have significant market potential. This has attracted the attention of multinational giants, Chinese pharmaceutical companies, and research institutions, who are actively investing in the development of various radioligand therapies.
Tigermed team is providing phase I-IV clinical solutions for radiation therapies and diagnosis including regulatory, clinical strategy, medical writing, medical monitoring, clinical operation, biometrics, pharmacovigilance, imaging analysis, import-export logistic, etc.
Therapeutic Expertise
The site uses cookies in order to collect data to provide general statistics to optimize site functionality and offer you a better experience. For more information, visit our Privacy Policy.